10.00 – 16.45

Innovation Forums

Biotherapeutics

The 2018 Biotherapeutic Forum of Basel Life will focus on new advancements in tissue specific delivery of biotherapeutics, cover exciting examples of site specific drug activation and novel approaches for intracellular targets. Join us to discover and discuss the latest developments in the field together with renowned experts from academia and industry.
Keywords:

• Delivery of Biotherapeutics to specific tissue site of action
• Biotherapeutic approaches for intracellular targets
• Tissue specific activation

Chairs:
Thomas Huber (Novartis, Basel, Switzerland)
Stefan Weigand (Roche, Basel, Switzerland)

10.00
ImmTAC: soluble TCR based bispecifics
Stephen Harper (Immunocore, Milton, United Kingdom)

10.30
TCR based therapeutics
Carsten Reinhardt (Immatics, Tübingen, Germany)

11.00
Antibody discovery at Syngene: multiple platforms for multiple scenarios
Priyadarshini Chatterjee (Syngene International, New Delhi, India)

11.45
Targeting intracellular proteins
Julia Neugebauer (Morphosys, München, Germany)

12.15
Intracellular delivery of antibodies
Andreas Plückthun (University of Zurich, Switzerland)

14.15
Targeting cell types by AAV for fundamental science or therapy
J. Krol
Institute of Molecular and Clinical Ophthalmology Basel (IOB), Basel, Switzerland

14.45
A versatile bacterial cancer therapy
S. Ittig
T3 Pharmaceuticals AG, Basel, Switzerland

15.45
Balancing selectivity and efficacy of bispecific antibodies
Lars Toleikis (Merck Group, Darmstadt, Germany)

16.15
A Brain Shuttle for safe and efficient large molecule transport to the brain
J. Niewoehner
pRED LMR Roche Innovation Center Munich, Roche, Penzberg, Germany

Shanghai 2